Eli Lilly’s weight-loss pill didn’t work so well, and the stock is tumbling




Lilly’s stock was tumbling as disappointing trial data for an oral weight-loss pill offset an upbeat earnings report and outlook.



Source link

More From Author

Links 8/7/2025 | naked capitalism

Federal Reserve, Using Non-Compliant Accounting, Hides Over $100 Billion a Year of Losses and Resulting Negative Equity, Due to Illegal Bank Subsidies

Leave a Reply

Your email address will not be published. Required fields are marked *